Blue Owl Capital Holdings »

Rallybio Corp shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Rallybio Corp (RLYB) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Rallybio Corp

Tip: Access up to 7 years of quarterly data

All positions including Rallybio Corp held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rallybio Corp by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $837k 350k 2.39

More positions owned by Blue Owl Capital Holdings

Pliant Therapeutics (PLRX)
Robinhood Mkts Com Cl A (HOOD)
Cullinan Oncology (CGEM)
Tourmaline Bio (TRML)
Klaviyo Com Ser A (KVYO)
Owl Rock Capital Corporation (OBDC)
Repare Therapeutics Ord (RPTX)
Acelyrin (SLRN)
Larimar Therapeutics (LRMR)
Keros Therapeutics (KROS)
Ultragenyx Pharmaceutical (RARE)
Engene Holdings (ENGN)
Syros Pharmaceuticals Com New (SYRS)
Disc Medicine (IRON)
E2open Parent Holdings Com Cl A (ETWO)

View all positions for Blue Owl Capital Holdings

Top funds holding Rallybio Corp

Viking Global Investors
5AM Venture Management
Tpg Gp A
Canaan Partners XI
Standard Life Aberdeen
Vanguard Group
Laurion Capital Management
Mariner Wealth Advisors
Blue Owl Capital Holdings
Citadel Advisors
Bank of New York Mellon
Charles Schwab Investment Management
Bank of America Corporation
Barclays
Rhumbline Advisers

View all funds holding Rallybio Corp